Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors

Marica Peron(University of Padua), Paolo Bonvini(University of Padua)

PLoS ONE

July 6, 2015

10.1371/journal.pone.0132330

Cited by 15

Related Papers

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma

|British Journal of Cancer|2013|25

Effect of inhibition of the Ubiquitin-Proteasome System and Hsp90 on growth and survival of Rhabdomyosarcoma cells in vitro

|BMC Cancer|2012|24

ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors

|PLoS ONE|2015|9